Invesco’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-303,802
Closed -$24.4M 3839
2016
Q4
$24.4M Buy
303,802
+613
+0.2% +$48.7K 0.01% 1078
2016
Q3
$24.2M Sell
303,189
-2,737
-0.9% -$221K 0.01% 1088
2016
Q2
$23.9M Sell
305,926
-48,142
-14% -$3.43M 0.01% 1079
2016
Q1
$19.5M Sell
354,068
-1,344
-0.4% -$73.2K 0.01% 1136
2015
Q4
$22M Buy
355,412
+27,820
+8% +$1.75M 0.01% 1103
2015
Q3
$20.7M Buy
327,592
+23,332
+8% +$1.67M 0.01% 1119
2015
Q2
$22.2M Sell
304,260
-17,624
-5% -$1.27M 0.01% 1160
2015
Q1
$21.1M Sell
321,884
-414,418
-56% -$27.6M 0.01% 1173
2014
Q4
$47.9M Buy
736,302
+26,534
+4% +$1.71M 0.02% 818
2014
Q3
$42.7M Sell
709,768
-28,486
-4% -$1.86M 0.02% 866
2014
Q2
$51.1M Sell
738,254
-26,808
-4% -$1.74M 0.02% 789
2014
Q1
$50M Buy
765,062
+434,924
+132% +$28.3M 0.02% 777
2013
Q4
$20.5M Buy
330,138
+23,747
+8% +$1.38M 0.01% 1174
2013
Q3
$16.4M Buy
306,391
+3,438
+1% +$177K 0.01% 1229
2013
Q2
$13.8M Buy
+302,953
New +$13.1M 0.01% 1267

Other funds holding STJ

Invesco's STJ Position: Q1 2017 in Review

Invesco sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 303,802 shares — an estimated $24.4M sold.

Invesco first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $51.1M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Invesco reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Invesco sold 303,802 St Jude Medical shares in Q1 2017, an estimated $24.4M.
  • Invesco first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Invesco's St Jude Medical position peaked at $51.1M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Invesco's 13F filing for Q1 2017, filed 15 May 2017.